Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABXB
3526
Abacus Flexible Bond Leaders ETF
ABXB
$1.92M
| $724K | ﹤0.01% |
28,749
-4,712
| -14% | -$118K |
|
3527
Alta Equipment Group
ALTG
$237M
| $723K | ﹤0.01% |
54,343
+304
| +0.6% | +$4.15K |
|
3528
America Movil
AMX
$70.3B
| $723K | ﹤0.01% |
48,168
-486,215
| -91% | -$7.23M |
|
3529
Bolt Biotherapeutics
BOLT
$6.44M
| $721K | ﹤0.01% |
2,331
+727
| +45% | +$295K |
|
3530
SK Telecom
SKM
$14.8B
| $718K | ﹤0.01% |
13,864
+4,263
| +44% | +$217K |
|
3531
Wave Life Sciences
WVE
$1.07B
| $715K | ﹤0.01% |
107,433
-14,901
| -12% | -$97.4K |
|
3532
SSR Mining
SSRM
$6.56B
| $713K | ﹤0.01% |
45,736
-225,540
| -83% | -$3.79M |
|
|
INFI
3533
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $711K | ﹤0.01% |
237,735
+174,698
| +277% | +$553K |
|
3534
LifeVantage
LFVN
$82.9M
| $709K | ﹤0.01% |
96,518
-32,193
| -25% | -$263K |
|
|
RTB
3535
RTB Digital
RTB
$237M
| $709K | ﹤0.01% |
+170
| New | +$716K |
|
3536
Clover Health Investments
CLOV
$2.44B
| $708K | ﹤0.01% |
53,176
+11,866
| +29% | +$117K |
|
|
GRDX
3537
GridAI Technologies Corp
GRDX
$29.5M
| $708K | ﹤0.01% |
7
+2
| +40% | +$215K |
|
3538
Oramed Pharmaceuticals
ORMP
$186M
| $707K | ﹤0.01% |
+52,904
| New | +$605K |
|
|
TAST
3539
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $705K | ﹤0.01% |
117,376
-2,181
| -2% | -$12.9K |
|
3540
LiveOne
LVO
$57.2M
| $703K | ﹤0.01% |
14,885
-2,232
| -13% | -$96.9K |
|
3541
Marqeta
MQ
$1.7B
| $703K | ﹤0.01% |
+6,262
| New | +$747K |
|
|
JNCE
3542
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $695K | ﹤0.01% |
102,268
+31,097
| +44% | +$258K |
|
|
HBMD
3543
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $695K | ﹤0.01% |
43,075
-128
| -0.3% | -$2.12K |
|
|
AFIB
3544
DELISTED
Acutus Medical Inc
AFIB
| $694K | ﹤0.01% |
40,913
-139,284
| -77% | -$2.04M |
|
3545
Cardiff Oncology
CRDF
$74.9M
| $693K | ﹤0.01% |
104,208
+89,859
| +626% | +$762K |
|
3546
First Northwest Bancorp
FNWB
$109M
| $693K | ﹤0.01% |
39,527
-22,755
| -37% | -$392K |
|
3547
Mayville Engineering Co
MEC
$614M
| $691K | ﹤0.01% |
34,337
+2,554
| +8% | +$45.1K |
|
|
FONR
3548
DELISTED
Fonar
FONR
| $690K | ﹤0.01% |
39,041
-16,794
| -30% | -$300K |
|
|
NGMS
3549
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $690K | ﹤0.01% |
11,234
-673
| -6% | -$35.1K |
|
|
ONCR
3550
DELISTED
Oncorus, Inc.
ONCR
| $690K | ﹤0.01% |
49,937
+32,192
| +181% | +$497K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.